Tracheostomy & Weaning From Mechanical Ventilation : Evaluation of

Clinical Trial Description

Prospective multicentric study on ICU evaluating Lung Ultrasound Score in tracheotomized patients during weaning from mechanical ventilation ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Tracheotomy

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02977767` - Evaluation of the Effect of Conversational Hypnosis When Changing Tracheal Cannula in Adult Patients	N/A
Completed	`NCT02406079` - Impact of Tracheotomy on Procalcitonin	N/A
Completed	`NCT04041817` - Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU	N/A

See also

Status

Clinical Trial

Phase

Withdrawn

NCT02977767 - Evaluation of the Effect of Conversational Hypnosis When Changing Tracheal Cannula in Adult Patients

N/A

Completed

NCT02406079 - Impact of Tracheotomy on Procalcitonin

N/A

Completed

NCT04041817 - Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01793363
Study type	Interventional
Source	University Hospital, Clermont-Ferrand
Contact
Status	Completed
Phase	N/A
Start date	August 2012
Completion date	November 2014

Tracheostomy and Weaning From Mechanical Ventilation : Evaluation of the Lung Ultrasound Score — TRAWELUS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms